Background: Norepinephrine (NE) plays a central role in post-traumatic stress disorder (PTSD). Dopamine β-hydroxylase (DβH) converts dopamine (DA) to NE and its activity varies widely across individuals. Mustapic et al. (2007) reported a PTSD-associated deficit in serum DβH activity in a genotype-controlled analysis of combat veterans. We tested whether such a deficit would occur in a sample of civilians. Methods: The severity of current adult PTSD symptoms and current DSM-IV diagnosis of PTSD were determined by the PTSD Symptom Scale (PSS). Adulthood trauma exposure was assessed using the Traumatic Experience Inventory (TEI). Serum DβH activity (sDβH) was assayed by HPLC with electrochemical detection and genotypes were determined using the Taqman® platform. Results: Two hundred and twenty seven African American (AA) subjects were enrolled in this study, with a mean age (±SD) of 42.9 (±12.9) years. We found a strong association between rs1611115 genotype and sDβH (p b 0.0001). After controlling for adulthood trauma exposure, there were no significant differences of sDβH between subjects who met a PTSD diagnosis and those who did not (p N 0.05) in any genotype group. No significant correlations were found between sDβH and PTSD severity, but sDβH significantly associated with the status of comorbid depression based on the cutoff of HAMD (p = 0.014) in subjects with PTSD. Conclusions: We have replicated in this sample the prior finding that DBH rs1611115 genotype strongly associates with sDβH. No associations between sDβH and PTSD diagnosis or symptom severity were found in this civilian sample.
Introduction
Norepinephrine (NE) is one of the principal mediators of central and peripheral autonomic stress responses. Because of its multiple roles in regulating arousal and autonomic stress responses, as well as promoting the encoding of emotional memories, NE has been a central focus of research in studies of the pathophysiology of PTSD (Heim and Nemeroff, 2009) . NE has been found to be directly linked to the pathophysiology of post-traumatic stress disorder (PTSD) (Southwick et al., 1999; Yehuda et al., 1992) . Cerebrospinal fluid (CSF) concentrations of NE are not only elevated in combat veterans with PTSD, but also correlate with the severity of PTSD symptoms (Geracioti et al., 2001) . Sustained hyperactivity of the sympathetic division of the autonomic nervous system is a prominent feature of PTSD, as evidenced by heart rate, blood pressure, skin conductance level, and other psychophysiological measures. Accordingly, increased urinary excretion of NE and epinephrine, and their metabolites, has been documented in combat veterans (Southwick et al., 1999; Yehuda et al., 1992) , abused women (Lemieux and Coe, 1995) , and children with PTSD (De Bellis et al., 1994; Delahanty et al., 2005) . In addition, patients with PTSD exhibit increased heart rate, blood pressure, and NE responses to challenge, such as traumatic reminders. Decreased platelet α 2 receptor binding further suggests NE hyperactivity in PTSD (Strawn and Geracioti, 2008; Vermetten and Bremner, 2002) . There is also evidence for a role of altered CNS NE function in PTSD. Administration of the α 2 receptor antagonist yohimbine, which increases NE release, induces symptoms of flashbacks and increased autonomic responses in patients with PTSD (Southwick et al., 1999) . Serial sampling revealed sustained increases in CSF NE concentrations and increased CSF NE responses to psychological stressors in PTSD (Geracioti et al., 2001 (Geracioti et al., , 2008 
